Stay updated on Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.

Latest updates to the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6, indicating a newer build/version of the page. This change appears to be an internal maintenance update rather than a visible modification to study content.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page no longer includes the ACT17131 Plain Language Results Summary, and the sponsor attribution line for Sanofi and Principia Biopharma as well as the 'Helpful Links Provided by' header have been removed, reducing lay-language results context, sponsor identification, and access to auxiliary links.SummaryDifference0.2%

- Check34 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a small maintenance or editorial update to the page rather than a change to study data or content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a small maintenance update. This change does not alter study information presented on the page.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision tag at the bottom now shows v3.6.3, replacing the previous v3.6.2. This change reflects a minor version update to the page metadata without altering displayed content.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now shows a new revision tag, updating from v3.6.0 to v3.6.2. This indicates a version metadata update rather than a change to study content or user-facing features.SummaryDifference0.0%

Stay in the know with updates to Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2a Study of Topical PRN473 in Atopic Dermatitis Clinical Trial page.